Oral cancer : part II
نویسندگان
چکیده
Squamous cell carcinoma and its histologic variants account for over 90% of all malignancies of the oral cavity. Early squamous cell carcinoma often presents as a white lesion (leukoplakia), red lesion (erythroplakia), or a combination of both (erythroleukoplakia). 1,2,3,4 However, with time, superficial ulceration of the mucosal surface may develop. As the lesion grows, it may become an exophytic mass with a fungating or papillary surface architecture. Some tumors demonstrate an endophytic growth pattern that is characterized by a depressed, ulcerated surface with a raised, rolled border. Pain is not a reliable indicator as to whether a particular lesion may be malignant and interestingly, most oral cancers will be totally asymptomatic or may be associated with only minor discomfort. The most common site for intraoral carcinoma is the tongue, which accounts for approximately 40% of all cases in the oral cavity proper. These tumors most frequently occur on the posterior lateral border and ventral surfaces of the tongue. The floor of the mouth is the second most common intraoral location. Less common sites include gingiva, buccal mucosa, and hard palate. The lateral tongue and floor of mouth combine to form a horseshoe-shaped region of oral mucosa, which is at greatest risk for cancer development. Two major factors help to explain why this region is at such a high risk. First, any carcinogen may mix with saliva, pool in the floor of the mouth, and constantly bathe these anatomic sites. Second, these regions of the mouth are covered by a thin, nonkeratinized mucosa, which provides less protection from carcinogens. 6 In addition to the oral cavity proper, squamous cell carcinomas also develop on the lip vermilion and the oropharynx. Vermillion carcinomas show a striking predilection for the lower lip, and usually occur in light-skinned individuals with a long history of solar damage. The lesion usually arises in an actinic cheilosis which is itself a premalignant condition. Actinic cheilosis is characterized by atrophy of the vermilion border which may develop dry, scaly changes. As the condition progresses, ulcerated sites may appear partially healed, only to recur at a later date. The evolving cancer slowly becomes a crusted, nontender, indurated ulcer or mass. Oropharyngeal carcinomas have a clinical appearance that is similar to cancers found in the oral cavity proper. Such tumors often arise on the lateral soft palate and tonsillar region, but also may originate from the base of the tongue. Unfortunately, such tumors are typically larger and more advanced at the time of discovery than compared to the more anteriorly located cancers of the oral cavity. Presenting symptoms often include difficulty in swallowing (dysphagia), pain during swallowing (odynophagia), and pain referred to the ear (otalgia).
منابع مشابه
Oral health in cancer therapy part II: Management of xerostomia and pain in cancer patients.
متن کامل
Oral Submucous Fibrosis: A Chronic Deliberating Disease of Oral Cavity
Oral submucous fibrosis is chronic progressive condition of oral cavity. The condition is well recognized for its malignant potential. Usually the disease initiates with redness, blistering, and ulceration inside the mouth. It is characterized by progressive fibrosis of submucosal tissue. The pathogenesis of oral submucous fibrosis is not well understood. Betelquid chewing is the major etiologi...
متن کاملA phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients.
PURPOSE Breast cancer resistance protein (ABCG2) substantially limits the oral bioavailability of topotecan. Coadministration with elacridar, an inhibitor of breast cancer resistance protein-mediated drug transport, increases the bioavailability of topotecan. The aim of this study was to establish the lowest effective dose of elacridar to obtain maximum oral bioavailability of topotecan and to ...
متن کاملManaging complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia.
Head and neck cancer is becoming a more recognizable pathology to the general population and dentists. The modes of treatment include surgery and/or radiation therapy. Where possible, pretreatment dental assessment shall be provided for these patients before they receive radiation therapy. There are occasions, however, whereby head and neck cancer patients are not prepared optimally for radiati...
متن کاملA review on the role of oral ginseng on erection dysfunction and fatigue in prostate cancer patients
Background: Current pharmacological and non-pharmacological treatment strategies for prostate cancer may control disease progression and increase the survival rates of patients but decreased quality of life is the most important concern of existing medical interventions. Erection dysfunction and fatigue are the most prevalent adverse effects of therapeutic procedures which impair the qual...
متن کاملA Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors.
Purpose: Rucaparib is a potent, oral, small-molecule PARP inhibitor. This phase I-II study was the first to evaluate single-agent oral rucaparib at multiple doses.Experimental Design: Part 1 (phase I) sought to determine the MTD, recommended phase II dose (RP2D), and pharmacokinetics of oral rucaparib administered in 21-day continuous cycles in patients with advanced solid tumors. Part 2A (phas...
متن کامل